drugset / Trial / NCT01523054

Metoprolol in Acute Myocardial Infarction. A PK/PD Study

NCT01523054

Phase 1 Completed 27 enrolled AstraZeneca
RandomizedParallel-groupOpen-labelBasic science

Summary

The objective of the study was to compare treatment with two different oral formulations of metoprolol, metoprolol immediate release (IR) and metoprolol extended release (CR/XL) in patients with acute myocardial infarction regarding the following: Pharmacokinetics, peak and trough plasma concentrations and area under the plasma concentration curve. Pharmacodynamics, hourly means of Holter recorded heart rate. Tolerability. An open, randomised design with two parallel groups was employed.

Timeline

Start
2000-02
Primary completion
2002-04
Completion
2002-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoprolol Other / unclassified 100 mg Oral
Comparator Metoprolol Other / unclassified 200 mg Oral